Fresh analysis suggests that patients who come off popular GLP-1 drugs like Wegovy and Mounjaro may regain lost weight far faster than those who halt conventional lifestyle programs.
Findings released in a leading health publication points out that while overweight people frequently drop a large proportion of their body weight while using the jabs, the mass comes back at an estimated rate of nearly a kilo each month upon discontinuation.
"Users purchasing these drugs need to be informed of the danger of fast weight regain when the treatment ends," cautioned expert Dr. Susan Jebb.
Such speed of recovery implies a return to starting weight in about one and a half years.
Comparing Therapies
The analysis, which examined dozens of trials involving thousands of participants, contrasted the effects of GLP-1 agonists with older methods.
Researchers emphasize that individuals who shed pounds through dieting typically see a slower weight regain—perhaps 0.1 kg a month—post-intervention.
The Reason for the Quick Regain
Experts believe the mode of action of the injections explains the heightened weight return.
GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which moderates appetite.
"Long-term administration of the hormone concentrations far above than normal could lead to the body to produce less of its own natural GLP-1, and could diminish sensitivity to its effects," explained Dr. Adam Collins, a nutrition expert.
"Stopping of this GLP-1 'fix' means appetite is unsuppressed, making binge eating far more likely."
A Chronic Condition?
Health authorities advise the jabs for individuals with obesity-related health risks, alongside recommended lifestyle changes.
A number of clinicians say that, given the likelihood of weight regain, the treatment should be considered life-long.
This view is echoed by drug manufacturers, who note that the results "emphasize the persistent nature of obesity," similar to managing conditions like hypertension.
Patient Testimonies
People who have stopped the jabs explain a intense return of cravings.
"I experienced something activating and you're instantly ravenous," described a patient.
This difficulty is worsened if patients have not established sustainable lifestyle or habit changes during therapy.
Widespread Use
Figures suggest that a significant number of people in the UK have tried these injections in the past year, with desire continuing to grow.
- Adoption is more common among females compared to males.
- The 40s and 50s age group shows the highest usage rates.
- Many obtain the drugs through private healthcare rather than public health services.
Ultimately, researchers stress that while GLP-1 drugs are powerful tools for shedding pounds, they are not a permanent fix and maintained weight loss hinges on integrated lifestyle management.
